CUSIP 16961L106Common Stock290AQ1 2025
23 filings · latest Nov 22, 2023
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Parallel Advisors, LLC | 5 | $0 |
| 2 | Farther Finance Advisors, LLC | 100 | $0 |
| 4 | Mar 10, 2023 | Versant Venture Capital Vii, L.P. | 13D/A | 3.2% | 2.11M | SEC |
| 5 | Feb 14, 2023 | Frazier Life Sciences Public Fund, L.P. | 13G/A | 4.9% | 3.13M | SEC |
| 6 | Feb 14, 2023 | Deep Track Capital, LP | 13G/A | 4.7% | 3.00M | SEC |
| 7 | Feb 14, 2023 | Point72 Asset Management, L.P. | 13G/A | 2.0% | 1.27M | SEC |
| 8 | Feb 1, 2023 | Blackrock Inc. | 13G/A | 6.2% | 3.95M | SEC |
| 9 | Dec 28, 2022 | Versant Venture Capital Vii, L.P. | 13D/A | 3.7% | 2.35M | SEC |
| 10 | Aug 22, 2022 | Versant Venture Capital Vii, L.P. | 13D/A | 4.6% | 2.91M | SEC |
See the full Schedule 13D/13G history for Chinook Therapeutics Inc.
Unlock full history